Medicine
TECENTRIQ 1 200 mg
Key ingredient(s)
0 Mg
Atezolizumab 1 200
Available forms & strengths
Request this medicine| Form | Strength | Pack | Route | Icon |
|---|---|---|---|---|
| INFUSION (PARENTERAL) | 1200,0 mg per 14,0 ml | — | Parenteral |
|
Notes: SAHPRA secureId: CfDJ8L67LitnFgdOq0Uv0zyh2botRbTzeMsZ1roRVIcPbmtgGaDMtyJWvP7epivHHSGuOkVZ6LNDmwvfAz3iA483LblvC9MgBiK6L03Lp3fDQ4VkjC47GbdxPvOQc8jXZeC1bw | Reg: 54/30.1/0061 | AppNo: 540061 | RegDate: 2020/09/29 | Applicant: Roche Products (Pty) Ltd | Status: Registered